small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (60)
  • Capabilities (32)
  • Experience (2)
  • Insights & News (73)
  • Other Results (15)

Professionals 60 results

Becky Troutman
Becky Troutman
Partner
  • San Francisco, 
  • Silicon Valley
Email
+1 415-591-1401
vCard

Partner

  • San Francisco
  • Silicon Valley
Michael Bittner
Michael Bittner
Partner
  • Dallas
Email
+1 214-453-6464
vCard

Partner

  • Dallas
Dustin Edwards
Dustin Edwards
Partner
  • Houston
Email
+1 713-651-2627
vCard

Partner

  • Houston
View All Professionals

Capabilities 32 results

Practice Area

Patent Litigation

Our Patent Litigation Practice is one of the country’s most active and highly regarded. Our seasoned patent litigators bring extensive courtroom experience
to every matter we handle. According to Lex Machina, we are among the top three national patent defense firms in the country for number of appearances
and cases filed, and we also were the top national defense firm for number of patent trials in the last five years (2018–2022).
...Read more

Practice Area

Trademark Litigation, Prosecution & Brand Protection

Practice Area

ITC – Section 337

The United States International Trade Commission (ITC) is an increasingly popular venue for patent infringement litigation. More and more companies are
seeking to halt importations of infringing products into the United States by turning to the ITC for expedited relief. Section 337 investigations conducted by the
ITC provide complainants with a “fast track” to remedy IP matters that typically go to trial within 10 months. Since many Section 337 cases go to ...Read more
...Read more

Experience 2 results

Experience

|

November 2, 2021

RCG Global Services’ Majority Recapitalization with Frontenac

Winston & Strawn LLP RCG Global Services (the Company), a global digital transformation consultancy providing product engineering, advanced analytics, and
cloud services to Fortune 1000 enterprises, has completed a majority recapitalization with Frontenac, a Chicago-based private equity firm. RCG was
previously majority owned by Eos Partners, L.P., a New York-based private investment firm. Financial terms of the transaction were not disclosed....Read more
...Read more

Experience

|

October 13, 2021

US$1.18B Green Financing for First North American Flood Prevention P3

Insights & News 73 results

In the Media

|

July 24, 2025

|

2 Min Read

Winston’s Digital Assets Lawyers Discuss the GENIUS Act with IFLR

Winston & Strawn Digital Assets Group co-chairs Kimberly Prior and Daniel Stabile and partner Yulia Makarova were featured in an IFLR article discussing the
GENIUS Act and how it is set to drive new client demand, complex advisory needs, and internal investment across legal teams. On July 18, President Trump
signed the stablecoin bill titled “Guiding and Establishing National Innovation for US Stablecoins Act of 2025” which marks the first federal regulat...Read more
...Read more

In the Media

|

June 25, 2025

|

1 Min Read

Yulia Makarova Joins Winston & Strawn in London Office

Winston & Strawn recently announced the arrival of Yulia Makarova to the firm’s London office. She joined as a partner in the Financial Innovation &
Regulation practice, where she advises innovative businesses operating in the distributed ledger, blockchain, and digital assets sectors, with a particular focus
on the domestic and cross-border application of financial services regulation. Yulia’s arrival marks a significant enhancement to the firm’s capabi...Read more
...Read more

Recognitions

|

June 3, 2025

|

1 Min Read

Winston Recognized in 2025 IAM Patent 1000 Rankings

Winston & Strawn’s Patent Litigation Practice has been recognized in the 2025 IAM Patent 1000 rankings. ...Read more
View All Insights & News

Other Results 15 results

Law Glossary

What Is a Generic Drug?

Generic drugs are typically small, chemically synthesized molecules—that is, they have relatively low molecular weights, frequently less than 1000 daltons
and usually between 300 and 700 daltons. Biosimilars, on the other hand, are typically substantially larger in molecular weight than small molecule drugs. For
example, a monoclonal antibody—a typical biosimilar drug—generally has a molecular weight in excess of 150,000 daltons. In contrast, aspirin—...Read more
...Read more

Location

São Paulo

Winston & Strawn’s São Paulo office reflects the firm’s long-term investment in Brazil and the significant commitment of Winston’s Latin America practice
group members to the country over many decades. Our fully bilingual São Paulo-based attorneys represent clients on international financing, cross-border
mergers and acquisitions, corporate governance, and disputes. They also act as a relationship touch point for global clients looking to expand int...Read more
...Read more

Location

New York

Winston & Strawn’s New York office opened in 1989 and has since grown to become the firm’s second-largest location, with 225+ lawyers distributed across
16 practice areas. Based in the iconic MetLife Building above Grand Central Station in Midtown Manhattan, our New York lawyers represent 80+ Fortune 500
companies from the city’s business epicenter. Our New York attorneys are tenacious and insightful, and they reflect the rich tapestry of New York...Read more
...Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising

We, our service providers, and other third parties use cookies and other analytics, advertising, and tracking technologies on this site. Your information, including personal information and interactions with this site, may be monitored, recorded, or collected through these tools and further used or disclosed by us, our service providers, and authorized third parties. For more details, please visit our privacy policy.